a public good project by the
Synthesis
Company
of California

© 2026

Philippe Ruminy | doi.page

0 works0 citations0 h-index

Philippe Ruminy

Inserm(FR)Normandie Université(FR)Université de Rouen Normandie(FR)

Publications by Year

Research Areas

Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, Cancer Genomics and Diagnostics, CAR-T cell therapy research, Viral-associated cancers and disorders

Most-Cited Works

→ Next-Generation Sequencing in Diffuse Large B-Cell Lymphoma Highlights Molecular Divergence and Therapeutic Opportunities: a LYSA Study(2016)194 cited
→ Mapping of MYC breakpoints in 8q24 rearrangements involving non-immunoglobulin partners in B-cell lymphomas(2007)154 cited
→ Diffuse large B-cell lymphomas with CDKN2A deletion have a distinct gene expression signature and a poor prognosis under R-CHOP treatment: a GELA study(2010)150 cited
→ Fetuin-B, a second member of the fetuin family in mammals(2000)143 cited
→ Follicular lymphoma cell niche: identification of a preeminent IL-4-dependent TFH–B cell axis(2010)132 cited
→ DC-SIGN–expressing macrophages trigger activation of mannosylated IgM B-cell receptor in follicular lymphoma(2015)130 cited

→ Biological and Clinical Relevance of Associated Genomic Alterations in MYD88 L265P and non-L265P–Mutated Diffuse Large B-Cell Lymphoma: Analysis of 361 Cases(2016)123 cited

→ Detection and prognostic value of recurrent exportin 1 mutations in tumor and cell-free circulating DNA of patients with classical Hodgkin lymphoma(2016)118 cited

→ Identification of Somatic Mutations in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type by Massive Parallel Sequencing(2017)114 cited

→ The proportion of activated B-cell like subtype among de novo diffuse large B-cell lymphoma increases with age(2011)114 cited